Showing results (51-60 of 316) with videos related to

Sort By:
Pageof 32
Molecular and Clinical Oncology|August 22, 2024
Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitorsKiyoshi Takahara, Taku Naiki, Keita Nakane, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 17, 2014
[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report]Daisuke Noro, Takahiro Yoneyama, Kazuhisa Hagiwara, et al.
Case Reports in Urology|February 17, 2015
A case of primary renal carcinoid tumorToshikazu Tanaka, Hayato Yamamoto, Atsushi Imai, et al.
BMC Urology|November 10, 2022
CALN1 hypomethylation as a biomarker for high-risk bladder cancerKimiaki Takagi, Azumi Naruse, Kazutoshi Akita, et al.
Nutrients|June 10, 2022
Prognostic Value of the Controlling Nutritional Status (CONUT) Score in Patients at Dialysis InitiationKimiaki Takagi, Hiroshi Takahashi, Tomomi Miura, et al.
Urology Case Reports|March 20, 2020
Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case reportManabu Takai, Daiki Kato, Koji Iinuma, et al.
Clinical and Experimental Nephrology|March 31, 2018
Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional studyTeppei Okamoto, Shingo Hatakeyama, Yoshimi Tanaka, et al.
Medical Oncology (Northwood, London, England)|December 5, 2014
Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancerTakuya Koie, Chikara Ohyama, Hayato Yamamoto, et al.
Case Reports in Oncology|November 20, 2014
Testicular metastasis of prostate cancer: a case reportAyumu Kusaka, Takuya Koie, Hayato Yamamoto, et al.
International Journal of Clinical Oncology|November 15, 2021
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysisTaku Naiki, Kiyoshi Takahara, Toshiki Ito, et al.
Pageof 32